Recombinant multi-species MASP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MASP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
The Alternative Names of target: 3MC1,CCPII,CRARF,CRARF1,Complement factor MASP-3,Complement-activating component of Ra-reactive factor,Crarf,MAP-1,MAP1,MASP,MASP-3,MASP1,MASP3,MAp44,Mannan-binding lectin serine protease 1,Mannose-binding lectin-associated serine protease 1 (MASP-1),Mannose-binding protein-associated serine protease,Masp1,Masp1/3,Masp3,PRSS5,RPIB9,Ra-reactive factor serine protease p100 (RaRF),RaRF,Serine protease 5
Go
to MASP1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1089-Ag-1/ GM-Tg-hg-SE1089-Ag-2 | Human MASP1 protein | Human |
| GM-Tg-rg-SE1089-Ag-1/ GM-Tg-rg-SE1089-Ag-2 | Rat MASP1 protein | Rat |
| GM-Tg-mg-SE1089-Ag-1/ GM-Tg-mg-SE1089-Ag-2 | Mouse MASP1 protein | Mouse |
| GM-Tg-cynog-SE1089-Ag-1/ GM-Tg-cynog-SE1089-Ag-2 | Cynomolgus/Rhesus macaque MASP1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1089-Ag-1/ GM-Tg-felg-SE1089-Ag-2 | Feline MASP1 protein | Feline |
| GM-Tg-cang-SE1089-Ag-1/ GM-Tg-cang-SE1089-Ag-2 | Canine MASP1 protein | Canine |
| GM-Tg-bovg-SE1089-Ag-1/ GM-Tg-bovg-SE1089-Ag-2 | Bovine MASP1 protein | Bovine |
| GM-Tg-equg-SE1089-Ag-1/ GM-Tg-equg-SE1089-Ag-2 | Equine MASP1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1089-Ag-1/ GM-Tg-hg-SE1089-Ag-2;
GM-Tg-rg-SE1089-Ag-1/ GM-Tg-rg-SE1089-Ag-2;
GM-Tg-mg-SE1089-Ag-1/ GM-Tg-mg-SE1089-Ag-2; GM-Tg-cynog-SE1089-Ag-1/ GM-Tg-cynog-SE1089-Ag-2; GM-Tg-felg-SE1089-Ag-1/ GM-Tg-felg-SE1089-Ag-2; GM-Tg-cang-SE1089-Ag-1/ GM-Tg-cang-SE1089-Ag-2; GM-Tg-bovg-SE1089-Ag-1/ GM-Tg-bovg-SE1089-Ag-2; GM-Tg-equg-SE1089-Ag-1/ GM-Tg-equg-SE1089-Ag-2 |
| Products Name | MASP1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MASP1 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MASP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.